News
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Popular weight loss medications like Ozempic can help reverse low testosterone levels in men with obesity or Type 2 diabetes, ...
3d
MedPage Today on MSNGLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, But Timing MattersSAN FRANCISCO -- In order to maximize weight loss, a GLP-1 receptor agonist may be needed both before and after bariatric ...
4d
MedPage Today on MSNMenopause Hormone Therapy Users May Lose More on Weight Loss InjectableAmong 120 women with overweight or obesity, MHT users lost 19.18% of their total body weight with tirzepatide (Mounjaro, ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
3d
New Scientist on MSNYou don't need to take drugs like Ozempic consistently to lose weightPeople who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...
Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...
10d
inews.co.uk on MSNWeight loss jabs to be given to 3,000 people in trial to get them back into workWeight loss jabs will be given to 3,000 people in a trial to explore whether they can get people back into work, The i Paper ...
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results